Beta
Back to RXRX.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
revenue-chart

RXRX Revenue

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for RXRX's revenue in Q4'25 shows a significant increase to $35.54M USD, marking a strong recovery and the highest quarterly figure in the observed period from Q1'23 to Q4'25. Over the timeframe from Q1'23 to Q4'25, revenue exhibited volatility with an initial decline from $12.13M in Q1'23 to a low of $10.53M in Q3'23, followed by moderate growth to $14.42M in Q2'24 and a sharp spike to $26.08M in Q3'24, before dipping to $4.55M in Q4'24. Subsequent quarters saw fluctuations, including a drop to $5.18M in Q3'25, but year-over-year growth turned highly positive at 681.74% in Q4'25, indicating robust expansion driven by potential new revenue streams or operational improvements, though the overall trend remains inconsistent with periods of contraction offsetting gains.